| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |